Donald Alec Lebsack

Title: The Innovations of Donald Alec Lebsack

Introduction

Donald Alec Lebsack is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptor activities in the body. His work is essential for advancing treatments for various diseases.

Latest Patents

Donald Alec Lebsack holds a patent for "Quinoline or isoquinoline substituted P2X7 antagonists." This invention relates to novel compounds that exhibit P2X7 antagonistic properties. The patent includes pharmaceutical compositions comprising these compounds, chemical processes for their preparation, and their application in treating or preventing diseases associated with P2X7 receptor activity in animals, particularly humans. He has 1 patent to his name.

Career Highlights

Lebsack is associated with Janssen Pharmaceutica NV, a company known for its innovative pharmaceutical solutions. His work at this organization has allowed him to contribute to the development of new therapeutic options that can improve patient outcomes.

Collaborations

Throughout his career, Donald has collaborated with notable colleagues, including Christopher John Love and Joseph Elisabeth Leenaerts. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Donald Alec Lebsack's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His work on P2X7 antagonists is a testament to the impact that dedicated inventors can have on healthcare.